CPT-11 and TS-1 + CPT-11, 5-FU and l-LV
Phase 2/3Completed 0 watching 0 views this week📈 Rising
65
Development Stage
✓
Pre-clinical✓
Phase 13
Phase 24
Phase 35
ApprovedIndication / Disease
Colorectal Cancer
Conditions
Colorectal Cancer
Trial Timeline
Jan 1, 2006 → Aug 1, 2010
NCT ID
NCT00284258About CPT-11 and TS-1 + CPT-11, 5-FU and l-LV
CPT-11 and TS-1 + CPT-11, 5-FU and l-LV is a phase 2/3 stage product being developed by Daiichi Sankyo for Colorectal Cancer. The current trial status is completed. This product is registered under clinical trial identifier NCT00284258. Target conditions include Colorectal Cancer.
Hype Score Breakdown
Clinical
22
Activity
15
Company
10
Novelty
7
Community
8
Clinical Trials (1)
| NCT ID | Phase | Status |
|---|---|---|
| NCT00284258 | Phase 2/3 | Completed |
Competing Products
20 competing products in Colorectal Cancer